⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL21585564 | 0.85 | SRC (0.37) | — | |
| SCHEMBL14905 | 0.79 | LTA4H (0.60) | — | |
| SCHEMBL17049455 | 0.76 | LTA4H (0.56) | — | |
| SCHEMBL9586944 | 0.76 | LTA4H (0.56) | — | |
| Methane SCHEMBL28804943 | 0.76 | LTA4H (0.56) | — | |
| SCHEMBL226327 | 0.73 | — | — | |
| SCHEMBL158272 | 0.73 | LTA4H (0.53) | — | |
| SCHEMBL11028002 | 0.73 | — | — | |
| SCHEMBL5492420 | 0.73 | LTA4H (0.53) | — | |
| SCHEMBL17599222 | 0.73 | LTA4H (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3293177-B1 | TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GUANGDONG RAYNOVENT BIOTECH CO LTD (CN) | 2024-11-27 | — | — | EP | disclosed |
| US-12006240-B2 | Method of suspending elemental sulfur in water | SOLENIS TECHNOLOGIES, L.P. (US) | 2024-06-11 | — | — | US | disclosed |
| EP-3856684-B1 | METHOD OF SUSPENDING ELEMENTAL SULFUR IN WATER | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2024-05-01 | — | — | EP | disclosed |
| CN-113785838-B | Combination fungicides containing chlorophenoxyamide and procymidone | 浙江农林大学 | 2022-11-22 | — | — | CN | disclosed |
| CN-115379877-A | Modulated waveform care device and method | NSE产品公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-114929739-A | Bispecific antibodies with alternatively matched interchain cysteines and uses thereof | 凡恩世制药公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-114158565-A | Bactericidal composition containing fenpyrazamine and chlorophenoxyacetic acid amide and application thereof | 青岛海利尔生物科技有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-113924144-A | Isopropyl carbonate benzoyl peroxide composition and using method thereof | 高德美控股有限公司 | 2022-01-11 | — | — | CN | disclosed |
| EP-3856684-A1 | METHOD OF SUSPENDING ELEMENTAL SULFUR IN WATER | Solenis Technologies Cayman, L.P. (KY) | 2021-08-04 | — | — | EP | disclosed |
| EP-3529238-B1 | BIS-DIOX(OL)ANE COMPOUNDS | COOEPERATIE KONINKLIJKE COSUN U A (NL) | 2021-07-07 | — | — | EP | disclosed |
| CN-1950351-B | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands | WARNER LAMBERT CO | 2012-01-18 | — | — | CN | disclosed |
| EP-1747210-B1 | 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS | WARNER LAMBERT CO (US) | 2010-06-30 | — | — | EP | disclosed |
| US-7456164-B2 | Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable | PFIZER, INC (US) | 2008-11-25 | — | — | US | disclosed |
| CN-1950351-A | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands | WARNER LAMBERT CO (US) | 2007-04-18 | — | — | CN | disclosed |
| EP-1747210-A1 | 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS | Warner-Lambert Company LLC (US) | 2007-01-31 | — | — | EP | disclosed |
| US-20050267095-A1 | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands | ZIARCO INC. | 2005-12-01 | — | — | US | disclosed |
| WO-2005108384-A1 | 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS | WARNER-LAMBERT COMPANY LLC (US) | 2005-11-17 | — | — | WO | disclosed |
| EP-1593679-A1 | 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands | Warner-Lambert Company LLC (US) | 2005-11-09 | — | — | EP | disclosed |
| US-5837723-A | METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE FOR TREATMENT OF CATARACTS, RETINAL DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-11-17 | — | — | US | disclosed |
| EP-0633025-A1 | Pharmaceutical composition containing 3-methyl-1-phenyl-2-pyrazolin-5-one for the treatment of ophthalmological diseases | Mitsubishi Chemical Corporation (JP) | 1995-01-11 | — | — | EP | disclosed |